New Peptide Powerhouses — Brain Cancer, Obesity & AI Design!
1. JM2: Precision Attack on Glioblastoma Stem Cells Virginia Tech researchers unveiled a synthetic peptide called JM2 that selectively targets glioblastoma stem cells—the root of recurrence in the most deadly brain cancer—as early as May 2025 Virginia Tech News+1Wikipedia+1. In preclinical models, JM2 disrupted stem-cell-driven tumor regrowth, suggesting a future “maintenance” therapy post standard treatment….
